{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T18:05:12Z","timestamp":1781460312464,"version":"3.54.1"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.cct.2025.108142","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T10:17:40Z","timestamp":1762769860000},"page":"108142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Enhanced trial efficiency of the novel \u201ccontemporaneous control recapture\u201d parallel-cohort RCT design: Methods and application in the CRITICAL-Kids-TP trial"],"prefix":"10.1016","volume":"160","author":[{"given":"Anthony A.","family":"Sochet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest K.","family":"Amankwah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Andalib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Jaffray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Male","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Vincent","family":"Faustino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil A.","family":"Goldenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.cct.2025.108142_bb0005","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1111\/1471-0528.15199","article-title":"Randomised controlled trials - the gold standard for effectiveness research: study design: randomised controlled trials","volume":"125","author":"Hariton","year":"2018","journal-title":"BJOG"},{"key":"10.1016\/j.cct.2025.108142_bb0010","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0197-2456(92)90005-K","article-title":"Analysis of randomized and non-randomized patients in clinical trials using the comprehensive cohort follow-up study design","volume":"13","author":"Olschewski","year":"1992","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.cct.2025.108142_bb0015","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1067\/mhj.2001.115297","article-title":"The pravastatin inflammation CRP evaluation (PRINCE): rationale and design","volume":"141","author":"AlbertM","year":"2001","journal-title":"Am. Heart J."},{"issue":"2","key":"10.1016\/j.cct.2025.108142_bb0020","doi-asserted-by":"crossref","DOI":"10.3399\/bjgpopen20X101154","article-title":"Recommendations for clinical research in children presenting to primary care out-of-hours services: a randomised controlled trial with parallel cohort study","volume":"5","author":"Weghorst","year":"2021","journal-title":"BJGP Open."},{"issue":"2","key":"10.1016\/j.cct.2025.108142_bb0025","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jtha.2024.09.038","article-title":"Duration of anticoagulation for venous thromboembolism in pediatric patients: evaluation of the duration of therapy for thrombosis in children (kids-DOTT) trial outcomes at 2 years","volume":"23","author":"Goldenberg","year":"2025","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.cct.2025.108142_bb0030","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cct.2009.11.006","article-title":"The \u201cparallel-cohort RCT\u201d: novel design aspects and application in the kids-DOTT trial of pediatric venous thromboembolism","volume":"31","author":"Goldenberg","year":"2010","journal-title":"Contemp. Clin. Trials"},{"issue":"3","key":"10.1016\/j.cct.2025.108142_bb0035","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1177\/0885066621998978","article-title":"A qualitative analysis of factors influencing critical care trial enrollment among surrogates","volume":"37","author":"Krutsinger","year":"2022","journal-title":"J. Intensive Care Med."},{"issue":"10","key":"10.1016\/j.cct.2025.108142_bb0040","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/j.1553-2712.2010.00866.x","article-title":"Recruitment and retention of patients into emergency medicine clinical trials","volume":"17","author":"Cofield","year":"2010","journal-title":"Acad. Emerg. Med."},{"issue":"4","key":"10.1016\/j.cct.2025.108142_bb0045","article-title":"Randomisation to protect against selection bias in healthcare trials","volume":"2011","author":"Odgaard-Jensen","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"issue":"4","key":"10.1016\/j.cct.2025.108142_bb0055","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.thromres.2015.04.036","article-title":"Development of a new risk score for hospital-associated venous thromboembolism in critically-ill children not undergoing cardiothoracic surgery","volume":"136","author":"Arlikar","year":"2015","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.cct.2025.108142_bb0060","first-page":"544","article-title":"Bivariate evaluation of thromboembolism and bleeding in clinical trials of anticoagulants in patients with atrial fibrillation","volume":"116","author":"Kittelson","year":"2016","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.cct.2025.108142_bb0065","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/08037059209077502","article-title":"Prospective randomized open blinded endpoint (PROBE) study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point","volume":"1","author":"Hansson","year":"1992","journal-title":"Blood Press."},{"issue":"2\u20133","key":"10.1016\/j.cct.2025.108142_bb0070","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0049-3848(03)00099-9","article-title":"An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial","volume":"109","author":"Massicotte","year":"2003","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.cct.2025.108142_bb0075","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1097\/CCM.0000000000004784","article-title":"Efficacy of early prophylaxis against catheter-associated thrombosis in critically ill children: a Bayesian phase 2b randomized clinical trial","volume":"49","author":"Faustino","year":"2021","journal-title":"Crit. Care Med."},{"issue":"2","key":"10.1016\/j.cct.2025.108142_bb0080","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1080\/19466315.2022.2071982","article-title":"Combining real-world and randomized control trial data using data-adaptive weighting via the on-trial score","volume":"15","author":"Harton","year":"2022","journal-title":"Stat. Biopharm. Res."},{"issue":"1","key":"10.1016\/j.cct.2025.108142_bb0085","doi-asserted-by":"crossref","first-page":"5783","DOI":"10.1038\/s41467-022-33192-1","article-title":"The design and evaluation of hybrid controlled trials that leverage external data and randomization","volume":"13","author":"Ventz","year":"2022","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.cct.2025.108142_bb0090","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann. Intern. Med."}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714425003362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714425003362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T17:43:53Z","timestamp":1781459033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714425003362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":17,"alternative-id":["S1551714425003362"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2025.108142","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced trial efficiency of the novel \u201ccontemporaneous control recapture\u201d parallel-cohort RCT design: Methods and application in the CRITICAL-Kids-TP trial","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2025.108142","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108142"}}